SCHEMBL1821273

SCHEMBL1821273

O=C(O)C1CC=COC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9084173 0.80
SCHEMBL301156 0.72
Hydrochloric Acid SCHEMBL11536308 0.69
SCHEMBL12491910 0.67 ABAT (0.48)
SCHEMBL12491864 0.67 ABAT (0.60)
SCHEMBL12491907 0.67 ABAT (0.48)
SCHEMBL3175913 0.67 ABAT (0.48)
SCHEMBL1029022 0.66
SCHEMBL574547 0.65
SCHEMBL28352421 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107176939-A A kind of new tripodia ketone ligand organic compound and preparation method and application 赵学辉 2017-09-19 CN claimed
CN-107176938-A A kind of triketone organic compound and preparation method and application 赵学辉 2017-09-19 CN claimed
US-8394813-B2 Active agent delivery systems and methods for protecting and administering active agents SHIRE LLC (US) 2013-03-12 US disclosed
EP-2316469-A1 Delivery system and methods for protecting and administering dextroamphetamine Shire LLC (US) 2011-05-04 EP disclosed
EP-2316468-A1 Delivery system and methods for protecting and administering dextroamphetamine Shire LLC (US) 2011-05-04 EP disclosed
EP-2266590-A2 Active agent delivery sytems and methods for protecting and administering active agents Shire LLC (US) 2010-12-29 EP disclosed
US-20090306228-A1 ACTIVE AGENT DELIVERY SYSTEMS AND METHODS FOR PROTECTING AND ADMINISTERING ACTIVE AGENTS SHIRE LLC (US) 2009-12-10 US disclosed
US-20090253792-A1 ACTIVE AGENT DELIVERY SYSTEMS AND METHODS FOR PROTECTING AND ADMINISTERING ACTIVE AGENTS SHIRE LLC (US) 2009-10-08 US disclosed
US-7427600-B2 Active agent delivery systems and methods for protecting and administering active agents SHIRE LLC (US) 2008-09-23 US disclosed
US-20070232529-A1 mesalamine covalently attached to carrier peptide at C-terminus, interspersed and/or side chain; releasing into bloodstream; reducing dosage NEW RIVER PHARMACEUTICALS INC. (US) 2007-10-04 US disclosed
EP-1490090-A4 ACTIVE AGENT DELIVERY SYSTEMS AND METHODS FOR PROTECTING AND ADMINISTERING ACTIVE AGENTS NEW RIVER PHARMACEUTICALS INC (US) 2006-09-20 EP disclosed
US-6472422-B2 TREATING DRUG ADDICTION GEORGETOWN UNIVERSITY 2002-10-29 US disclosed
US-6440996-B1 Monomeric and dimeric heterocycles, and therapeutic uses thereof GEORGETOWN UNIVERSITY 2002-08-27 US disclosed
US-20020055521-A1 Analogs of cocaine NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2002-05-09 US disclosed
EP-1119553-A1 MONOMERIC AND DIMERIC HETEROCYCLES, AND THERAPEUTIC USES THEREOF GEORGETOWN UNIVERSITY (US) 2001-08-01 EP disclosed
US-6180648-B1 Analogs of cocaine BIOSTREAM THERAPEUTICS, INC. 2001-01-30 US disclosed
WO-2000020390-A1 MONOMERIC AND DIMERIC HETEROCYCLES, AND THERAPEUTIC USES THEREOF GEORGETOWN UNIVERSITY (US) 2000-04-13 WO disclosed
EP-0975595-A1 ANALOGS OF COCAINE GEORGETOWN UNIVERSITY (US) 2000-02-02 EP disclosed
WO-1998045263-A1 ANALOGS OF COCAINE GEORGETOWN UNIVERSITY (US) 1998-10-15 WO disclosed
CN-87101230-A New chroman derivatives and its preparation method 1988-06-29 CN disclosed